Taysha Gene Therapies, Inc.

NASDAQ:TSHA

Biotechnology

Healthcare
$3.77 +1.53%

+$0.10 today

Market cap
$1.22B
Beta
1.18
P/E (TTM)
-17.7
EPS (TTM)
-$0.35
52W Low $2.25High $7.30

Volume 2.17M

Average 2.73M

Price history

Taysha Gene Therapies, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-5.51%

Period high

$6.98

Period low

$3.51

Latest

$3.77

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
4Jul 10, 2026Jul 10, 2026
8-KJun 25, 2026Jun 25, 2026
424B5Jun 25, 2026Jun 25, 2026
424B5Jun 24, 2026Jun 24, 2026
8-KJun 22, 2026Jun 22, 2026
4Jun 2, 2026Jun 2, 2026
4Jun 2, 2026Jun 2, 2026
4Jun 2, 2026Jun 2, 2026
8-KJun 2, 2026Jun 2, 2026

Competitors

Who does Taysha Gene Therapies, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about TSHA's filings, answered from its disclosures.

What is the latest TSHA filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does TSHA have?

Intrinsic Alpha currently shows 20 recent filings for TSHA.